You are at the center of everything we do at Seattle Cancer Care Alliance (SCCA). Here, we surround you with a team of specialists who work together closely to provide expertly targeted, complete care and compassionate support throughout your treatment and beyond.
We guide you every step of the way, combining our deep clinical expertise in non-Hodgkin lymphoma with a commitment to meet your unique needs.
Request an appointment
Call (855) 557-0555 or fill out our online form to request an appointment, refer a patient or learn more about cancer care at SCCA.
Why choose SCCA for non-Hodgkin lymphoma treatment?
Lymphoma survival rates
Lymphoma patients who begin treatment at SCCA have better survival rates on average than those who started treatment elsewhere.
Experts in non-Hodgkin lymphoma
Your SCCA medical oncologist, radiation oncologist and pathologist specialize in identifying your specific type, subtype and stage of lymphoma and providing a combination of advanced treatments tailored to you.
Comprehensive lymphoma treatment
People with lymphoma have better hope of a cure and long-term survival than ever. Based on the specific features of your disease, your team may recommend watchful waiting, chemotherapy, radiation therapy, targeted therapy, immunotherapy or bone marrow transplant, all available at SCCA.
Non-Hodgkin lymphoma clinical trials
To give you access to the most innovative therapies, SCCA unites the leading researchers and cancer specialists of Fred Hutch and UW Medicine so you can take part in non-Hodgkin lymphoma clinical studies not available everywhere.
New FDA-approved CAR T-cell therapies
SCCA is one of the first cancer centers in the nation to offer both FDA-approved cellular immunotherapies for non-Hodgkin lymphoma. Tisagenlecleucel, known as the brand name Kymriah®, and axicabtagene ciloleucel (axi-cel), known by the brand name Yescarta®, are CAR T-cell therapies available only at certified treatment centers.
Bone marrow transplant for lymphoma
The Fred Hutch Bone Marrow Transplant Program at SCCA consistently achieves higher-than-expected transplant survival rates. We pioneered bone marrow transplants and have performed more than any other institution in the world.
A national leader in cancer care
SCCA is the leading cancer treatment center in the region and among the top nationally, according to U.S. News & World Report.
NCI comprehensive cancer center
We are a comprehensive cancer center, a designation from the National Cancer Institute that reflects our scientific leadership and the depth and breadth of our research to prevent, diagnose and treat cancer.